RP11-407N17.3 | CTAGE family member 5 isoform 4 | Predicted membrane proteins
| | | | | Tissue enhanced |
RP11-944C7.1 | Protein LOC100506792 | | | | | | Tissue enhanced |
SCIN | Scinderin | Cytoskeleton related proteins Plasma proteins
| | | | | Tissue enhanced |
SDCBP2 | Syndecan binding protein (syntenin) 2 | | | | | | Tissue enhanced |
SECTM1 | Secreted and transmembrane 1 | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
SH2D6 | SH2 domain containing 6 | | | | | | Tissue enhanced |
SIGLEC15 | Sialic acid binding Ig-like lectin 15 | Predicted membrane proteins
| | | | | Tissue enhanced |
SLC13A1 | Solute carrier family 13 (sodium/sulfate symporter), member 1 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC14A2 | Solute carrier family 14 (urea transporter), member 2 | Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC1A1 | Solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC1A7 | Solute carrier family 1 (glutamate transporter), member 7 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC23A1 | Solute carrier family 23 (ascorbic acid transporter), member 1 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC28A2 | Solute carrier family 28 (concentrative nucleoside transporter), member 2 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC2A5 | Solute carrier family 2 (facilitated glucose/fructose transporter), member 5 | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
SLC51B | Solute carrier family 51, beta subunit | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC6A20 | Solute carrier family 6 (proline IMINO transporter), member 20 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SMPD3 | Sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II) | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
SOWAHA | Sosondowah ankyrin repeat domain family member A | Predicted secreted proteins
| | | | | Tissue enhanced |
SSUH2 | Ssu-2 homolog (C. elegans) | | | | | | Tissue enhanced |
SULT1C3 | Sulfotransferase family, cytosolic, 1C, member 3 | Enzymes
| | | | | Tissue enhanced |
TM4SF5 | Transmembrane 4 L six family member 5 | Predicted membrane proteins
| | | | | Tissue enhanced |
TM6SF2 | Transmembrane 6 superfamily member 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
TMC5 | Transmembrane channel-like 5 | Predicted membrane proteins
| | | | | Tissue enhanced |
TMEM150B | Transmembrane protein 150B | Predicted membrane proteins
| | | | | Tissue enhanced |
TMEM252 | Transmembrane protein 252 | Predicted membrane proteins
| | | | | Tissue enhanced |
TMEM45B | Transmembrane protein 45B | Predicted membrane proteins
| | | | | Tissue enhanced |
TMEM74B | Transmembrane protein 74B | Predicted membrane proteins
| | | | | Tissue enhanced |
TRIM15 | Tripartite motif containing 15 | | | | | | Tissue enhanced |
TRIM40 | Tripartite motif containing 40 | | | | | | Tissue enhanced |
TRPC7 | Transient receptor potential cation channel, subfamily C, member 7 | Predicted membrane proteins Voltage-gated ion channels
| | | | | Tissue enhanced |
TRPM5 | Transient receptor potential cation channel, subfamily M, member 5 | Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Tissue enhanced |
TSPAN8 | Tetraspanin 8 | Cancer-related genes Predicted membrane proteins
| | | | | Tissue enhanced |
UCN3 | Urocortin 3 | Predicted secreted proteins
| | | | | Tissue enhanced |
UGT2A3 | UDP glucuronosyltransferase 2 family, polypeptide A3 | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
UNC5CL | Unc-5 homolog C (C. elegans)-like | | | | | | Tissue enhanced |
URAD | Ureidoimidazoline (2-oxo-4-hydroxy-4-carboxy-5-) decarboxylase | Enzymes
| | | | | Tissue enhanced |
VDR | Vitamin D (1,25- dihydroxyvitamin D3) receptor | Disease related genes FDA approved drug targets Nuclear receptors Transcription factors
| | | | | Tissue enhanced |
XKR9 | XK, Kell blood group complex subunit-related family, member 9 | Predicted membrane proteins
| | | | | Tissue enhanced |
ZNF488 | Zinc finger protein 488 | Predicted secreted proteins
| | | | | Tissue enhanced |